재조합 인슐린 치료 중 발생한 혈중 인슐린농도의 비정상적 상승 증례에 대한 고찰 = Unusually Elevated Serum Insulin Level in a Diabetic Patient during Recombinant Insulin Therapy

다국어 초록 (Multilingual Abstract)

Herein, we report a case of unusually elevated serum insulin level as a result of increased anti-insulin antibody (IA)-bound insulin after continuous subcutaneous insulin infusion therapy. Detecting free insulin (unbound IAs) levels after polyethylene glycol pre-treatment could be useful to assess functional insulin levels in diabetic patients receiving insulin therapy. The E170 insulin assay can estimate total insulin (bound IAs and free insulin) levels, but it does not measure the levels of exogenous insulin analogues.

참고문헌 (Reference)

1 Sapin R., "The interference of insulin antibodies in insulin immunometric assays" 40 : 7058-, 2002

2 김세림, "The Effects of Anti-insulin Antibodies and Cross-reactivity with Human Recombinant Insulin Analogues in the E170 Insulin Immunometric Assay" 대한진단검사의학회 31 (31): 22-29, 2011

3 Hanning I, "Measurement of free insulin concentrations: the influence of the timing of extraction of insulin antibodies" 28 : 8315-, 1985

4 Sapin R., "Insulin assays: previously known and new analytical features" 49 : 11321-, 2003

5 Kim MR, "Insulin antibodies and hypoglycemia in diabetic patients. Can a quantitative analysis of antibody binding predict the risk of hypoglycemia?" 6 : 28591-, 1997

6 Fineberg SE, "Immunological responses to exogenous insulin" 28 : 62552-, 2007

7 Jeandidier N, "Immunogenicity of intraperitoneal insulin infusion using programmable implantable devices" 38 : 57784-, 1995

8 Koyama R, "Hypoglycemia and hyperglycemia due to insulin antibodies against therapeutic human insulin: treatment with double filtration plasmapheresis and prednisolone" 329 : 25964-, 2005

9 Arnqvist H, "Free and total insulin as determined after precipitation with polyethylene glycol: analytical characteristics and effects of sample handling and storage" 33 : 936-, 1987

10 Owen WE, "Crossreactivity of three recombinant insulin analogs with five commercial insulin immunoassays" 50 : 2579-, 2004

11 Radermecker RP, "Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control" 25 : 491501-, 2009

12 Sapin R, "Antiinsulin antibodies in insulin immunometric assays: a still possible pitfall" 35 : 3657-, 1997

13 Hara K, "Antibodymediated insulin resistance treated by cessation of insulin administration" 39 : 1435-, 2000

14 Cao Y, "A sensitive chemiluminescent enzyme immunoassay for the bioanalysis of carboxylterminal Bchain analogues of human insulin" 26 : 5361-, 2001